[Renal and cardiac functions as prognostic factors after revascularization for myocardial infarction]

R Reibis1, J Herbstleb, W Kamke

  • 1Klinik am See, Fachklinik für Innere Medizin, Rüdersdorf b. Berlin, Germany. rona.reibis@hotmail.de <rona.reibis@hotmail.de>

Insights

Prognosis after myocardial infarction reperfusion is influenced by left ventricular ejection fraction (LVEF), left bundle branch block, and renal function. These factors significantly impact patient survival post-treatment.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Medical Research

Context:

  • Optimal treatment for myocardial infarction (MI) involves reperfusion therapies and secondary prevention.
  • Prognostic factors following MI treatment remain an area of active investigation.
  • Understanding post-MI prognosis is crucial for patient management and risk stratification.

Purpose:

  • To identify key factors influencing patient prognosis after myocardial infarction (MI) reperfusion therapy.
  • To analyze the impact of various clinical parameters on mortality and adverse events post-MI.
  • To determine predictors of long-term outcomes in patients undergoing revascularization for MI.

Summary:

  • A prospective multicenter registry study followed 926 patients post-MI revascularization.
  • Left ventricular ejection fraction (LVEF), left bundle branch block, and elevated serum creatinine were significant predictors of mortality.
  • Conventional risk factors and prior treatments did not significantly influence outcomes.

Impact:

  • Identifies critical indicators for assessing mortality risk in post-MI patients.
  • Highlights the importance of LVEF, renal function, and conduction abnormalities in prognosis.
  • Informs clinical decision-making and patient counseling regarding long-term outcomes after MI.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...